Treatment and Prevention of Experimental Autoimmune Myocarditis with CD28 Superagonists

Publisher： Karger

E-ISSN： 1421-9751|115|2|107-113

ISSN： 0008-6312

Source： Cardiology, Vol.115, Iss.2, 2009-11, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibrinogen‐like protein‐2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death‐1 and inflammatory cytokines

By  

IMMUNOLOGY, Vol. 153, Iss. 2, 2018-02 ,pp. : 246-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

IL‐17‐producing CD4+ T cells contribute to the loss of B‐cell tolerance in experimental autoimmune myasthenia gravis

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 1339-1347

John Wiley & Sons Inc

Access to resources Recommend Favorite

B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1563-1575

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Candida glabrata Myocarditis with Voriconazole

By Einarsdóttir Hulda M.   Danielsen Ragnar   Gottfredsson Magnús  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 10, 2002-10 ,pp. : 778-780

Informa Healthcare

Access to resources Recommend Favorite

Treatment Options for Autoimmune Cytopenias

By  

Transfusion Medicine and Hemotherapy, Vol. 31, Iss. 5, 2004-10 ,pp. : 332-340

Karger

Access to resources Recommend Favorite